BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29334255)

  • 21. Clinical features and prognostic impact of TCF3-PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China.
    Jia M; Hu BF; Xu XJ; Zhang JY; Li SS; Tang YM
    Curr Probl Cancer; 2021 Dec; 45(6):100758. PubMed ID: 34034913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.
    Li JF; Dai YT; Lilljebjörn H; Shen SH; Cui BW; Bai L; Liu YF; Qian MX; Kubota Y; Kiyoi H; Matsumura I; Miyazaki Y; Olsson L; Tan AM; Ariffin H; Chen J; Takita J; Yasuda T; Mano H; Johansson B; Yang JJ; Yeoh AE; Hayakawa F; Chen Z; Pui CH; Fioretos T; Chen SJ; Huang JY
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11711-E11720. PubMed ID: 30487223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocols.
    Ribera J; Granada I; Morgades M; González T; Ciudad J; Such E; Calasanz MJ; Mercadal S; Coll R; González-Campos J; Tormo M; García-Cadenas I; Gil C; Cervera M; Barba P; Costa D; Ayala R; Bermúdez A; Orfao A; Ribera JM;
    Br J Haematol; 2022 Feb; 196(3):670-675. PubMed ID: 34549416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The first case of elderly
    Takeda R; Yokoyama K; Ogawa M; Kawamata T; Fukuyama T; Kondoh K; Takei T; Nakamura S; Ito M; Yusa N; Shimizu E; Ohno N; Uchimaru K; Yamaguchi R; Imoto S; Miyano S; Tojo A
    Leuk Lymphoma; 2019 Nov; 60(11):2821-2824. PubMed ID: 31058556
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
    Paulsson K; Jonson T; Ora I; Olofsson T; Panagopoulos I; Johansson B
    Br J Haematol; 2007 Jul; 138(2):196-201. PubMed ID: 17593026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cells.
    Piao J; Takai S; Kamiya T; Inukai T; Sugita K; Ohyashiki K; Delia D; Masutani M; Mizutani S; Takagi M
    Cancer Lett; 2017 Feb; 386():131-140. PubMed ID: 27894958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A clinical and laboratory study of TCF3-PBX1 positive adult acute lymphoblastic leukemia.].
    Zheng JF; Qiu HY; Pan JL; Cen JN; Wu YF; Zhang J; Wu DP; Xue YQ
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jan; 31(1):16-20. PubMed ID: 20302770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excellent outcome of acute lymphoblastic leukaemia with TCF3-PBX1 rearrangement in Hong Kong.
    Lin A; Cheng FWT; Chiang AKS; Luk CW; Li RCH; Ling ASC; Cheuk DKL; Chang KO; Ku D; Lee V; Ha SY; Li CK
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27346. PubMed ID: 30051646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Durable remissions in
    Mouttet B; Vinti L; Ancliff P; Bodmer N; Brethon B; Cario G; Chen-Santel C; Elitzur S; Hazar V; Kunz J; Möricke A; Stein J; Vora A; Yaman Y; Schrappe M; Anak S; Baruche A; Locatelli F; von Stackelberg A; Stanulla M; Bourquin JP
    Haematologica; 2019 Jun; 104(6):e244-e247. PubMed ID: 30765470
    [No Abstract]   [Full Text] [Related]  

  • 30. Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia.
    Eldfors S; Kuusanmäki H; Kontro M; Majumder MM; Parsons A; Edgren H; Pemovska T; Kallioniemi O; Wennerberg K; Gökbuget N; Burmeister T; Porkka K; Heckman CA
    Leukemia; 2017 Jan; 31(1):51-57. PubMed ID: 27461063
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Naskar S; Paul T; Kulkarni JD; Anand KC; Divya V; Rambhojun HD
    Leuk Lymphoma; 2024 Jun; 65(6):852-856. PubMed ID: 38407197
    [No Abstract]   [Full Text] [Related]  

  • 32. Rare
    Miyamoto S; Urayama KY; Arakawa Y; Koh K; Yuza Y; Hasegawa D; Taneyama Y; Noguchi Y; Yanagimachi M; Inukai T; Ota S; Takahashi H; Keino D; Toyama D; Takita J; Tomizawa D; Morio T; Koike K; Moriwaki K; Sato Y; Fujimura J; Morita D; Sekinaka Y; Nakamura K; Sakashita K; Goto H; Manabe A; Takagi M
    Pediatr Hematol Oncol; 2024; 41(1):81-87. PubMed ID: 37129918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylome analysis of acute lymphoblastic leukemia cells reveals stochastic de novo DNA methylation in CpG islands.
    Wahlberg P; Lundmark A; Nordlund J; Busche S; Raine A; Tandre K; Rönnblom L; Sinnett D; Forestier E; Pastinen T; Lönnerholm G; Syvänen AC
    Epigenomics; 2016 Oct; 8(10):1367-1387. PubMed ID: 27552300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
    Baudis M; Prima V; Tung YH; Hunger SP
    Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic features of B-cell lymphoblastic lymphoma with TCF3-PBX1.
    Shirai R; Osumi T; Sato-Otsubo A; Nakabayashi K; Mori T; Yoshida M; Yoshida K; Kohri M; Ishihara T; Yasue S; Imamura T; Endo M; Miyamoto S; Ohki K; Sanada M; Kiyokawa N; Ogawa S; Yoshioka T; Hata K; Takagi M; Kato M
    Cancer Rep (Hoboken); 2022 Sep; 5(9):e1559. PubMed ID: 34553842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic deregulation in pediatric acute lymphoblastic leukemia.
    Chatterton Z; Morenos L; Mechinaud F; Ashley DM; Craig JM; Sexton-Oates A; Halemba MS; Parkinson-Bates M; Ng J; Morrison D; Carroll WL; Saffery R; Wong NC
    Epigenetics; 2014 Mar; 9(3):459-67. PubMed ID: 24394348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA gene methylation landscape in pediatric B-cell precursor acute lymphoblastic leukemia.
    Chaber R; Gurgul A; Tabarkiewicz J; Wróbel G; Szmatoła T; Jasielczuk I; Haus O; Lejman M; Rybka B; Ryczan-Krawczyk R; Jaśkowiec A; Paszek S; Potocka N; Arthur CJ; Bal W; Łach K; Kowal A; Zawlik I; Latos-Grażyńska E
    Adv Clin Exp Med; 2022 Mar; 31(3):293-305. PubMed ID: 35092653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New E2A/PBX1 fusion transcript in a patient with t(1;19)(q23;p13) acute lymphoblastic leukemia.
    Numata S; Kato K; Horibe K
    Leukemia; 1993 Sep; 7(9):1441-4. PubMed ID: 8103813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of the ETV6-RUNX1, BCR-ABL1, TCF3-PBX1, and MLL-AFF1 fusion genes in Guatemalan pediatric acute lymphoblastic leukemia patients and their ethnic associations.
    Carranza C; Granados L; Morales O; Jo W; Villagran S; Tinti D; Villegas M; Antillón F; Torselli S; Silva G
    Cancer Genet; 2013 Jun; 206(6):227-32. PubMed ID: 23859904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.